$0.1740
0.00020.12%
Last update: Oct 27, 7:33 PM
Vistagen Therapeutics Inc
VTGNNASDAQ
Vistagen Therapeutics (VTGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.35 | $-0.30 | $-0.39 | $-0.47 |
| Actual | $-0.30 | $-0.37 | $-0.45 | $-0.54 |
| Surprise | +14.3% | -23.3% | -15.4% | -14.9% |
| Revenue | ||||
| Estimate | $166670 | $320000 | $256520 | $339480 |
| Actual | $1.5M | $465000 | $303000 | $258000 |
| Surprise | +785.6% | +45.3% | +18.1% | -24.0% |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.37 | $-0.36 | $-0.35 | $0.03 |
| Revenue | ||||
| Consensus | $250000 | $250000 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | Aug 14, 2026 | $-0.30 | $-0.35 | 14.3 % |
| Q4 | Jun 15, 2026 | $-0.37 | $-0.30 | -23.3 % |
| Q3 | Feb 12, 2026 | $-0.45 | $-0.39 | -15.4 % |
| Q2 | Nov 13, 2025 | $-0.54 | $-0.47 | -14.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | Aug 14, 2026 | $1.48M | $166.67K | 785.6 % |
| Q4 | Jun 15, 2026 | $465.00K | $320.00K | 45.3 % |
| Q3 | Feb 12, 2026 | $303.00K | $256.52K | 18.1 % |
| Q2 | Nov 13, 2025 | $258.00K | $339.48K | -24.0 % |
